Cytek Biosciences (CTKB) Goodwill & Intangibles (2020 - 2026)

Cytek Biosciences has reported Goodwill & Intangibles for 7 years, with the latest figure at $32.4 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill & Intangibles fell 10.29% year-over-year to $32.4 million; the trailing twelve-month figure through Mar 2026 stood at $32.4 million (down 10.29% YoY), and the FY2025 full-year result was $33.5 million, down 8.9% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $32.4 million, down from $33.5 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $43.8 million in Q1 2023, with the low at $14.0 million in Q2 2022.
• Historically, Goodwill & Intangibles has averaged $32.1 million across 5 years, with a median of $36.1 million in 2025.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles soared 1647.79% — and 2024, when it declined 12.26%.
• Cytek Biosciences' Goodwill & Intangibles stood at $14.5 million in 2022, then soared by 171.27% to $39.3 million in 2023, then retreated by 6.31% to $36.8 million in 2024, then dropped by 8.9% to $33.5 million in 2025, then fell by 3.36% to $32.4 million in 2026.
• The last three Goodwill & Intangibles figures came in at $32.4 million (Q1 2026), $33.5 million (Q4 2025), and $34.4 million (Q3 2025), per Business Quant data.